Tango Therapeutics (TNGX) Q4 2022 Earnings

27MarConfirmed
May 22
Aug 22
Nov 22
Q4 2022
-0.35
-0.33
-0.3
-0.28

Details

Expected EPS
-0.35
Actual EPS
-0.33
Surprise EPS
0.02
Surprise Percent
+5.71%

Description

Tango Therapeutics (TNGX) has reported earnings of -0.33 per share for Q4 2022.

0 Comments

Share your thoughts